CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Z.
Right arrow Articles by Weiss, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Z.
Right arrow Articles by Weiss, A.
Cell Growth & Differentiation Vol. 13, 285-296, July 2002
© 2002 American Association for Cancer Research

The Inducible Expression of the Tumor Suppressor Gene PTEN Promotes Apoptosis and Decreases Cell Size by Inhibiting the PI3K/Akt Pathway in Jurkat T Cells1

Zheng Xu, David Stokoe, Lawrence P. Kane and Arthur Weiss2

Departments of Medicine and of Microbiology and Immunology and the Howard Hughes Medical Institute, University of California, San Francisco, California 94143-0795 [Z. X., L. P. K., A. W.], and Cancer Research Institute, University of California, San Francisco, California 94115 [D. S.]

In this study, we characterize the function of the tumor suppressor gene PTEN in Jurkat T cells. We established stable clones of Jurkat T cells that inducibly express either wild-type or phosphatase-inactive PTEN. We show here that PTEN potently inhibited the growth and reduced the size of Jurkat cells. The growth-suppressive effect of PTEN was associated with its ability to induce apoptotic cell death with little or no effect on cell cycle. PTEN also rendered Jurkat cells more susceptible to apoptosis induced by various stimuli. Furthermore, PTEN expression led to a reduction in the level of 3'-phosphorylated phospholipids and thus altered the activity and localization of Akt. Finally, coexpression of constitutively active Akt reversed the effects caused by PTEN. In summary, our results suggest that PTEN suppresses cell growth, promotes apoptosis, and decreases cell size by negatively regulating the phosphoinositide 3-kinase/Akt pathway in Jurkat T cells.




This article has been cited by other articles:


Home page
haematolHome page
R. D. Mendes, K. Cante-Barrett, R. Pieters, and J. P. P. Meijerink
The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia
Haematologica, September 1, 2016; 101(9): 1010 - 1017.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Y. Chan, D. Punwani, T. A. Kadlecek, M. J. Cowan, J. L. Olson, E. F. Mathes, U. Sunderam, S. Man Fu, R. Srinivasan, J. Kuriyan, et al.
A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70
J. Exp. Med., February 8, 2016; 213(2): 155 - 165.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Natarajan, A. August, and A. J. Henderson
Combinatorial Signals from CD28 Differentially Regulate Human Immunodeficiency Virus Transcription in T Cells
J. Biol. Chem., June 4, 2010; 285(23): 17338 - 17347.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. Raulic, Y. Ramos-Valdes, and G. E DiMattia
Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro
J. Endocrinol., June 1, 2008; 197(3): 517 - 529.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
D. Beach, R. Gonen, Y. Bogin, I. G. Reischl, and D. Yablonski
Dual Role of SLP-76 in Mediating T Cell Receptor-induced Activation of Phospholipase C-{gamma}1
J. Biol. Chem., February 2, 2007; 282(5): 2937 - 2946.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Nyakern, A. Cappellini, I. Mantovani, and A. M. Martelli
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways.
Mol. Cancer Ther., June 1, 2006; 5(6): 1559 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R.-i. Fukuda, A. Hayashi, A. Utsunomiya, Y. Nukada, R. Fukui, K. Itoh, K. Tezuka, K. Ohashi, K. Mizuno, M. Sakamoto, et al.
Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL)
PNAS, October 18, 2005; 102(42): 15213 - 15218.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Gao, R. L. Wange, N. Zhang, J. J. Oppenheim, and O. M. Z. Howard
Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN
Blood, October 15, 2005; 106(8): 2619 - 2626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Dombroski, R. A. Houghtling, C. M. Labno, P. Precht, A. Takesono, N. J. Caplen, D. D. Billadeau, R. L. Wange, J. K. Burkhardt, and P. L. Schwartzberg
Kinase-Independent Functions for Itk in TCR-Induced Regulation of Vav and the Actin Cytoskeleton
J. Immunol., February 1, 2005; 174(3): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. A. Lacalle, C. Gomez-Mouton, D. F. Barber, S. Jimenez-Baranda, E. Mira, C. Martinez-A., A. C. Carrera, and S. Manes
PTEN regulates motility but not directionality during leukocyte chemotaxis
J. Cell Sci., December 1, 2004; 117(25): 6207 - 6215.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Gendron, J. Couture, and F. Aoudjit
Integrin {alpha}2{beta}1 Inhibits Fas-mediated Apoptosis in T Lymphocytes by Protein Phosphatase 2A-dependent Activation of the MAPK/ERK Pathway
J. Biol. Chem., December 5, 2003; 278(49): 48633 - 48643.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Ge, O. Li, P. Wilder, A. Rizzino, and T. W. McKeithan
NF-{kappa}B Regulates BCL3 Transcription in T Lymphocytes Through an Intronic Enhancer
J. Immunol., October 15, 2003; 171(8): 4210 - 4218.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Freeburn, K. L. Wright, S. J. Burgess, E. Astoul, D. A. Cantrell, and S. G. Ward
Evidence That SHIP-1 Contributes to Phosphatidylinositol 3,4,5-Trisphosphate Metabolism in T Lymphocytes and Can Regulate Novel Phosphoinositide 3-Kinase Effectors
J. Immunol., November 15, 2002; 169(10): 5441 - 5450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2002 by the American Association of Cancer Research.